The 2-Minute Rule for ABBV-744 and other BRD4 inhibitors comparison
These side effects ended up notably milder compared to an inhibitor of equally bromodomains. An in depth molecular Assessment also uncovered that ABBV-744 preferentially inhibits the expression of Androgen Receptor (AR)-dependent genes. ― Stephen TaylorFeasible new approaches with the prognosis and treatment of AML. (A) The identification of su